Skip to main content
Equibles

LEVEL FOUR ADVISORY SERVICES, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1696715 DALLAS, TX
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$4,984,188
+$731,342 QoQ
Shares Held
10,034
+5.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#480
of 1,745 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LEVEL FOUR ADVISORY SERVICES, LLC holds $9,160,165 across 9 Biotechnology names. VRTX ranks #1 (54.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		10,034 $4,984,188
2 GMAB
Genmab A/S
 58,000 $1,593,260
3 ARGX
Argenx SE
 1,148 $1,065,079
4 JAZZ
Jazz Pharmaceuticals plc
 3,490 $840,985
5 TVTX
Travere Therapeutics, Inc.
 5,506 $312,795
6 REGN
Regeneron Pharmaceuticals, Inc.
 396 $246,921
7 MNKD
Mannkind Corp
 21,338 $90,899
8 OCGN
Ocugen, Inc.
 17,000 $26,010

All Filings in VRTX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,984,188 10,034
2026-03-31 $4,252,846 9,524
2025-12-31 $4,330,948 9,553
2025-09-30 $2,970,981 7,586
2025-06-30 $3,317,185 7,451
2025-03-31 $4,089,941 8,436
2024-12-31 $3,006,960 7,467
2024-09-30 $3,270,907 7,033
2024-06-30 $3,363,066 7,175
2024-03-31 $3,145,107 7,524
2023-12-31 $2,960,531 7,276
2023-09-30 $2,631,000 7,566
2023-06-30 $2,650,234 7,531
2023-03-31 $2,361,764 7,496
2022-12-31 $2,284,538 7,911
2022-09-30 $2,498,730 8,630
2022-06-30 $2,505,676 8,892
2022-03-31 $2,430,674 9,314
2021-12-31 $2,026,249 9,227
2021-09-30 $1,778,166 9,803
2020-06-30 $251,118 865